| The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans A Berkenstam, J Kristensen, K Mellström, B Carlsson, J Malm, ... Proceedings of the National Academy of Sciences 105 (2), 663-667, 2008 | 200 | 2008 |
| Thyroid Receptor Ligands. 1. Agonist Ligands Selective for the Thyroid Receptor β1 L Ye, YL Li, K Mellström, C Mellin, LG Bladh, K Koehler, N Garg, ... Journal of Medicinal Chemistry 46 (9), 1580-1588, 2003 | 164 | 2003 |
| Data validation using signatures and sampling N Garg, CD Carter, K Rajasekaran, DJ Martin, PK Singh US Patent 8,051,288, 2011 | 144 | 2011 |
| How does the electronegativity of the substituent dictate the strength of the gauche effect? C Thibaudeau, J Plavec, N Garg, A Papchikhin, J Chattopadhyaya Journal of the American Chemical Society 116 (9), 4038-4043, 1994 | 120 | 1994 |
| Design and Fast Synthesis of C-Terminal Duplicated Potent C2-Symmetric P1/P1‘-Modified HIV-1 Protease Inhibitors M Alterman, HO Andersson, N Garg, G Ahlsén, S Lövgren, B Classon, ... Journal of medicinal chemistry 42 (19), 3835-3844, 1999 | 103 | 1999 |
| Mitigating data usage in messaging applications NS Nayak, NK Garg US Patent 8,015,249, 2011 | 91 | 2011 |
| Data validation using signatures and sampling N Garg, CD Carter, K Rajasekaran, DJ Martin, PK Singh US Patent 7,484,096, 2009 | 79 | 2009 |
| Configuring security mechanisms utilizing a trust system N Garg, J Brewer, A Panasyuk US Patent 7,853,992, 2010 | 59 | 2010 |
| Optimization of P1–P3 groups in symmetric and asymmetric HIV‐1 protease inhibitors HO Andersson, K Fridborg, S Löwgren, M Alterman, A Mühlman, ... European journal of biochemistry 270 (8), 1746-1758, 2003 | 54 | 2003 |
| Rating and settlements engine S Shariff, IN Deb, N Garg, G Gopalakrishnan US Patent 7,505,962, 2009 | 48 | 2009 |
| New enzymatic and mass spectrometric methodology for the selective investigation of gut microbiota-derived metabolites C Ballet, MSP Correia, LP Conway, TL Locher, LC Lehmann, N Garg, ... Chemical science 9 (29), 6233-6239, 2018 | 46 | 2018 |
| Systems and methods for establishing in-band connections using out-of-band connections J Jance, NK Garg US Patent App. 13/745,669, 2014 | 40 | 2014 |
| Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress N Bonagas, NMS Gustafsson, M Henriksson, P Marttila, R Gustafsson, ... Nature cancer 3 (2), 156-172, 2022 | 39 | 2022 |
| Chemoselective probe containing a unique bioorthogonal cleavage site for investigation of gut microbiota metabolism N Garg, LP Conway, C Ballet, MSP Correia, FKS Olsson, M Vujasinovic, ... Angewandte Chemie International Edition 57 (42), 13805-13809, 2018 | 39 | 2018 |
| Nickel-catalyzed cross-coupling of ammonia or primary alkylamines with (hetero) aryl sulfamates, carbamates, or pivalates PM MacQueen, M Stradiotto Synlett 28 (13), 1652-1656, 2017 | 38 | 2017 |
| Thyroid receptor ligands. Part 5: Novel bicyclic agonist ligands selective for the thyroid hormone receptor β AMG Collazo, KF Koehler, N Garg, M Färnegårdh, B Husman, L Ye, ... Bioorganic & medicinal chemistry letters 16 (5), 1240-1244, 2006 | 37 | 2006 |
| Heck arylation of 1, 2-cyclohexanedione and 2-ethoxy-2-cyclohexenone N Garg, M Larhed, A Hallberg J Org Chem 63, 4158, 1998 | 37 | 1998 |
| Thyroid receptor ligands. Part 4: 4′-amido bioisosteric ligands selective for the thyroid hormone receptor beta YL Li, C Litten, KF Koehler, K Mellström, N Garg, AMG Collazo, ... Bioorganic & medicinal chemistry letters 16 (4), 884-886, 2006 | 35 | 2006 |
| Thyroid receptor ligands and method II J Hangeland, M Zhang, Y Caringal, D Ryono, YL Li, J Malm, Y Liu, N Garg, ... US Patent 6,989,402, 2006 | 33 | 2006 |
| Gaming notifications aggregator L Ye, N Garg, R Jain, SJ Cupala, E Hull US Patent 8,805,939, 2014 | 32 | 2014 |
